This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
650 |
4. Check minimum number of eventsNone |
650 |
5. Include endpointsNone |
650 |
6. Filter based on genotype QC (FinnGen only) |
614 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Disorders in reading
based on the number of shared cases.
Similar with more cases:
- Specific development disorders of scholastic skills
- Speech and linguistic disorders, excluding more controls
- Speech and linguistic disorders
- Disorders of psychological development
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 614 | 315 | 299 |
| Unadjusted period prevalence (%) | 0.12 | 0.11 | 0.14 |
| Median age at first event (years) | 14.81 | 17.56 | 11.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 650
- Matched controls
- 6500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F81.0
ICD-10 Finland
Specific reading disorder
10290.8
307.7
608
6
F81.1
ICD-10 Finland
Specific spelling disorder
219.3
93.0
94
5
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.2
72.9
188
471
F80.1
ICD-10 Finland
Expressive language disorder
9.7
51.9
63
71
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
50.1
215
765
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
48.5
46
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.6
48.4
101
206
N06BA04
ATC
methylphenidate; oral
4.2
45.7
146
421
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
15.9
44.6
39
26
Z2445
NOMESCO Finland
Psychologist
4.4
44.2
130
352
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
10.9
40.9
45
44
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
10.7
40.2
45
45
F80.2
ICD-10 Finland
Receptive language disorder
8.9
35.1
45
54
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.3
34.7
98
255
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
31.9
177
714
ZY010
NOMESCO Finland
Hospital outpatient
3.6
29.6
112
357
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.5
28.7
42
59
N05AH04
ATC
quetiapine; oral
2.7
26.8
195
899
N06AX16
ATC
venlafaxine; oral
3.0
26.3
136
522
N06AX21
ATC
duloxetine; oral
3.4
23.8
96
317
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.2
23.7
67
173
Z2446
NOMESCO Finland
Social worker
3.1
23.3
114
422
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
22.8
114
427
N06AX11
ATC
mirtazapine; oral
2.3
21.1
213
1123
N06AB03
ATC
fluoxetine; oral
3.0
20.3
102
382
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
20.2
89
309
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.5
20.1
51
121
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
19.9
19
*
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
30.0
19.8
26
9
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
19.7
155
729
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
6.2
19.7
34
57
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.6
19.1
66
196
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.2
18.9
80
271
Z2221
NOMESCO Finland
Medical doctor
2.2
18.8
205
1108
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
18.8
72
229
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
18.6
73
236
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
18.2
80
277
N06AB04
ATC
citalopram; systemic
2.7
18.2
116
492
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
7.5
17.9
26
36
Z3231
NOMESCO Finland
Registered nurse
2.2
17.8
219
1239
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.7
17.7
60
176
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.2
17.6
76
260
F82
ICD-10 Finland
Specific developmental disorder of motor function
5.0
17.0
37
77
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
16.9
68
223
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.5
16.8
61
187
N06BA12
ATC
lisdexamfetamine; oral
4.6
16.8
41
94
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
16.7
83
308
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.3
16.3
43
105
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
16.3
55
161
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.4
16.2
41
97
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.4
16.1
62
198
N06AB10
ATC
escitalopram; oral
2.1
15.8
188
1042
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
15.7
116
526
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
4.0
15.4
45
119
N06AG02
ATC
moclobemide; oral
5.6
15.1
29
54
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
14.7
72
265
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.4
14.4
55
174
Z3226
NOMESCO Finland
Physiotherapist
2.2
14.3
137
693
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.3
14.3
55
175
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
14.3
63
218
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
14.3
199
1163
ZXA05
NOMESCO Finland
Left side
2.5
14.1
103
463
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
13.9
203
1204
N06AB06
ATC
sertraline; oral
2.3
13.4
115
555
N06BA09
ATC
atomoxetine; oral
5.9
13.3
24
42
N05AX08
ATC
risperidone; systemic
2.8
13.3
69
262
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
41.0
13.2
16
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
12.7
123
623
S18
ICPC
Laceration/cut
1.9
12.7
245
1588
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
12.6
55
189
SPAT1283
SPAT
Restricted health certificate
1.9
12.6
234
1497
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.6
12.6
42
122
L12
ICPC
Hand/finger symptom/complaint
2.1
12.6
145
787
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
12.5
79
331
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.8
12.5
360
2633
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.1
12.5
149
818
ZXE00
NOMESCO Finland
One hour or less
1.9
12.5
252
1654
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
12.4
215
1343
SFA20
NOMESCO Finland
Two-surface restoration
1.8
12.3
403
3060
F34.1
ICD-10 Finland
Dysthymia
3.5
12.3
43
129
D01
ICPC
Abdominal pain/cramps general
2.1
12.1
129
678
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
8.9
12.1
25
29
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.7
12.0
39
111
E66.8
ICD-10 Finland
Other obesity
3.4
12.0
45
141
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
11.9
95
443
A05
ICPC
Feeling ill
2.2
11.9
115
582
N03AX09
ATC
lamotrigine; oral
2.8
11.8
62
236
K02.1
ICD-10 Finland
Caries of dentine
1.9
11.7
465
3718
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.7
11.6
37
104
XW000
NOMESCO Finland
Bone marrow biopsy
5.3
11.3
23
45
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
11.3
73
309
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.2
169
1004
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
11.1
80
357
SFA10
NOMESCO Finland
One-surface restoration
1.8
11.0
413
3215
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
11.0
101
500
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
11.0
262
1792
R4110
NOMESCO Finland
Physiotherapy
1.9
11.0
155
900
R03AC03
ATC
terbutaline; inhalant
2.3
10.9
89
419
R03AC02
ATC
salbutamol; inhalant
1.7
10.9
367
2767
P06
ICPC
Sleep disturbance
2.2
10.9
99
488
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.7
327
2392
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.4
10.6
27
64
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
10.5
508
4237
N06AX12
ATC
bupropion; oral
2.3
10.4
87
413
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.3
10.4
21
41
N03AG01
ATC
valproic acid; systemic, rectal
2.7
10.3
56
217
N05CF01
ATC
zopiclone; oral
2.1
10.3
117
627
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
10.2
89
430
P76
ICPC
Depressive disorder
2.3
10.2
79
363
P24
ICPC
Specific learning problem
3.7
10.2
32
89
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
10.2
528
4473
TAB00
NOMESCO Finland
Lumbar puncture
3.1
10.1
43
146
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
10.0
322
2376
N05BA04
ATC
oxazepam; oral
1.9
10.0
141
817
R74
ICPC
Upper respiratory infection acute
1.7
9.9
320
2361
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.9
9.9
152
904
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
9.9
64
271
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.8
9.8
49
182
N05AH03
ATC
olanzapine; systemic
2.4
9.7
70
312
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.3
9.6
36
113
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.5
9.6
63
269
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
9.5
125
705
N05AX12
ATC
aripiprazole; systemic
2.5
9.4
60
252
D06
ICPC
Abdominal pain localized other
2.3
9.4
72
330
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.7
9.4
29
80
R03BA02
ATC
budesonide; inhalant
2.0
9.3
119
665
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.3
9.2
24
58
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.3
9.2
77
366
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.9
9.2
44
160
SPAT1307
SPAT
Psychosocial counselling and guidance
2.0
9.1
104
558
KMAK, ,
NOMESCO Finland
1.7
9.1
321
2406
R02
ICPC
Shortness of breath/dyspnoea
2.3
9.1
74
348
K04.08
ICD-10 Finland
Other specified pulpit
2.2
9.0
77
369
A29
ICPC
General symptom/complaint other
2.3
9.0
74
349
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
8.9
58
246
-, ,
ICD-10 Finland
8.1
8.9
19
24
L17
ICPC
Foot/toe symptom/complaint
1.8
8.9
177
1136
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
8.9
69
318
M79.6
ICD-10 Finland
Pain in limb
1.7
8.8
225
1547
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.7
8.7
49
194
R51.80
ICD-10 Finland
Headache
1.8
8.7
141
851
SPAT1139
SPAT
Nutrition survey
4.5
8.7
21
48
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.6
486
4088
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
8.4
8.6
18
22
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
8.6
85
432
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
2.1
8.6
83
418
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.1
8.6
23
57
N06AX22
ATC
agomelatine; oral
3.4
8.6
30
90
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
8.6
115
652
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
8.6
54
226
RS220, ,
NOMESCO Finland
4.3
8.5
22
53
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.4
8.5
58
252
F84.5
ICD-10 Finland
Asperger syndrome
4.0
8.5
24
62
N06AX26
ATC
vortioxetine; oral
2.2
8.4
75
366
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
8.3
112
635
RS221, ,
NOMESCO Finland
3.9
8.3
24
63
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
8.3
110
621
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
8.2
165
1059
N05BA01
ATC
diazepam; systemic, rectal
2.3
8.1
65
303
G47.3
ICD-10 Finland
Sleep apnoea
2.0
8.1
90
478
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.4
8.0
29
89
R5599
NOMESCO Finland
Other rehabilitation service
3.4
8.0
29
89
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.0
89
472
M54.5
ICD-10 Finland
Low back pain
1.7
8.0
204
1396
A01
ICPC
Pain general/multiple sites
2.4
8.0
55
240
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
7.9
254
1841
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.7
7.8
24
66
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
7.8
179
1190
SPAT1310
SPAT
Counselling related to known health issue
1.6
7.8
214
1491
IEP03
NOMESCO Finland
Focused parental counselling
4.3
7.8
20
48
R4190
NOMESCO Finland
Nutritional therapy
2.4
7.7
54
237
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
7.7
255
1858
A02BC02
ATC
pantoprazole; systemic
1.6
7.7
281
2099
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
7.7
43
170
SFA30
NOMESCO Finland
Three-surface restoration
1.7
7.7
202
1392
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.6
7.6
25
72
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.6
160
1038
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.2
7.6
20
49
L02
ICPC
Back symptom/complaint
2.0
7.6
84
445
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
7.6
50
214
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.0
7.5
21
54
N06AA12
ATC
doxepin; systemic
4.0
7.5
21
54
ZXA10
NOMESCO Finland
Bilateral
1.9
7.5
97
543
R06.0
ICD-10 Finland
Dyspnoea
1.8
7.4
115
681
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
7.4
46
191
UJF32
NOMESCO Finland
Coloscopy
2.0
7.4
83
441
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.1
7.4
30
99
J01AA02
ATC
doxycycline; systemic
1.6
7.3
315
2433
N01
ICPC
Headache
1.7
7.3
161
1055
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.2
7.3
28
89
WX002
NOMESCO Finland
Sedation and analgesia
2.0
7.3
82
436
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
7.2
118
712
F81.2
ICD-10 Finland
Specific disorder of arithmetical skills
30.4
7.2
9
*
N06AX05
ATC
trazodone; oral
3.8
7.1
21
56
RD210, ,
NOMESCO Finland
2.7
7.1
37
141
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
7.1
149
965
A03
ICPC
Fever
1.6
7.0
188
1295
N05AB03
ATC
perphenazine; systemic, rectal
3.4
7.0
25
76
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
7.0
218
1560
SGA01
NOMESCO Finland
Emergency treatment
1.8
7.0
116
702
N05AA02
ATC
levomepromazine; systemic
3.2
6.9
27
87
P03
ICPC
Feeling depressed
1.8
6.9
120
735
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
6.9
84
461
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.2
6.9
18
44
H52.0
ICD-10 Finland
Hypermetropia
3.1
6.8
28
93
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
6.8
163
1090
H02AB06
ATC
prednisolone; systemic
1.6
6.8
211
1505
G44.2
ICD-10 Finland
Tension-type headache
1.9
6.8
88
492
F80.0
ICD-10 Finland
Specific speech articulation disorder
4.3
6.8
17
40
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
6.8
29
99
N06AX18
ATC
reboxetine; oral
16.9
6.8
10
6
IEP02
NOMESCO Finland
Child-centred family therapy
4.0
6.7
19
49
R96
ICPC
Asthma
2.3
6.7
50
226
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
6.7
536
4742
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
6.5
6.7
16
25
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
6.7
29
100
F84.8
ICD-10 Finland
Other pervasive developmental disorders
7.9
6.6
14
18
XCK00
NOMESCO Finland
Perimetry
3.3
6.6
24
74
J45.8
ICD-10 Finland
Mixed asthma
3.4
6.6
23
69
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.6
170
1159
WX290, ,
SPAT
2.5
6.6
40
165
C07AA05
ATC
propranolol; systemic
1.7
6.5
140
909
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
6.5
38
154
ZX120
NOMESCO Finland
Intravenous
2.3
6.5
48
217
127
Kela drug reimbursment
Transplant complication
3.8
6.4
19
51
F40.1
ICD-10 Finland
Social phobias
2.3
6.4
48
218
J01DA01
ATC
[U] cefalexin
1.5
6.3
311
2449
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.7
6.3
33
126
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
6.3
124
786
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
6.3
42
181
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
6.3
26
87
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
6.3
6
*
F61.0
ICD-10 Finland
Mixed personality disorders
3.7
6.2
19
52
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.2
6.2
24
77
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.2
6.2
53
254
R01AD09
ATC
mometasone; nasal
1.5
6.2
276
2125
K86
ICPC
Hypertension uncomplicated
3.6
6.2
20
57
SPAT1260
SPAT
Consultation of another employee
1.8
6.2
104
631
ZXD20
NOMESCO Finland
Day surgery
2.0
6.1
72
389
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
6.1
34
134
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.1
79
442
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.1
100
603
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.6
6.0
35
141
R42
ICD-10 Finland
Dizziness and giddiness
1.9
6.0
83
473
T82
ICPC
Obesity
2.8
6.0
29
106
R11
ICD-10 Finland
Nausea and vomiting
2.0
6.0
70
377
WX290
NOMESCO Finland
Other blockage of nerve
1.5
6.0
377
3110
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
2.9
6.0
27
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
186
919
2.43
21.43
2.6
1.8
1.54
1.37
%
2.59
172
853
306
1881
2.18
20.78
7.8
5.6
9.99
10.61
umol/l
0.54
292
1762
268
1591
2.16
19.60
5.0
3.4
33.23
30.44
u/l
0.25
256
1514
174
900
2.27
17.61
2.3
2.3
152.54
322.37
u/l
1.33
160
866
429
3117
2.11
17.60
7.5
6.1
82.63
85.60
u/l
0.58
413
2932
288
1822
2.04
17.21
14.7
7.7
1.21
1.21
mmol/l
0.48
259
1609
86
321
2.94
17.14
5.2
4.4
—
—
—
0
0
194
1062
2.18
17.00
3.8
3.0
1.02
1.02
kg/l
0.74
15
154
495
3843
2.21
16.47
4.3
3.7
14.33
14.42
pmol/l
0.41
478
3553
268
1686
2.00
15.97
16.0
7.6
1.22
1.22
mmol/l
0.13
253
1577
246
1502
2.03
15.94
8.4
5.7
37.99
38.06
g/l
0.07
230
1415
199
1140
2.07
15.24
2.7
2.7
2.36
2.36
mmol/l
0.36
181
1044
564
4688
2.53
14.96
18.5
9.3
3.89
3.91
mmol/l
0.84
552
4514
563
4679
2.52
14.88
18.6
9.3
139.70
139.55
mmol/l
1.03
552
4527
204
1191
2.04
14.77
4.1
3.8
9.14
8.97
mmol/l
0.15
196
1087
500
4004
2.08
13.77
3.7
2.7
5.67
5.54
mmol/l
1.37
476
3714
132
677
2.19
13.28
4.2
2.8
0.85
0.64
e6/l
0.34
79
357
396
2955
1.87
13.16
15.1
9.1
3.95
3.81
e9/l
0.64
347
2566
50
158
3.34
13.16
2.5
2.8
65.68
66.60
g/l
0.28
44
150
538
4476
2.17
12.67
5.0
4.2
1.77
2.04
mu/l
0.51
518
4223
202
1245
1.90
12.10
1.7
1.5
97.47
96.90
pmol/l
0.07
113
683
222
1437
1.83
11.25
4.7
3.4
—
—
—
0
0
188
1167
1.86
10.83
4.8
3.3
0.22
0.19
e6/l
0.12
146
869
420
3303
1.77
10.60
4.6
3.8
8.73
7.46
mm/h
1.71
396
3076
179
1110
1.85
10.27
9.5
4.9
93.96
91.96
%
0.55
174
1091
266
1863
1.72
10.02
3.1
2.7
62.94
69.04
nmol/l
3.64
253
1751
79
370
2.29
9.78
2.4
1.6
—
—
—
0
0
146
864
1.89
9.64
3.3
2.9
8.41
7.53
e6/l
0.20
128
771
329
2466
1.68
9.45
10.1
4.9
6.22
6.28
mmol/l
0.16
304
2212
62
266
2.47
9.33
13.3
11.3
0.59
0.40
mmol/l
0.11
45
213
590
5263
2.31
9.05
12.8
7.7
33.21
28.07
u/l
0.93
577
5100
77
372
2.21
8.84
2.4
1.6
—
—
—
0
0
438
3576
1.69
8.75
4.7
3.5
36.99
37.14
mmol/mol
0.10
420
3404
44
166
2.77
8.56
1.7
1.9
7.15
6.76
ug/l
0.04
38
150
581
5175
2.16
8.55
16.0
9.6
21.47
20.81
mg/l
0.19
477
3779
82
412
2.13
8.53
1.6
1.6
1086.72
1087.88
nmol/l
0.00
68
330
305
2296
1.62
8.23
3.8
3.0
0.00
0.00
estimate
0.50
36
478
178
1170
1.72
8.13
3.2
2.7
54.74
57.61
u/l
0.33
163
1093
75
375
2.13
7.90
17.3
8.2
104.99
104.89
mmol/l
0.08
75
375
88
469
2.01
7.82
2.2
2.3
2.39
2.40
mmol/l
0.45
73
401
104
592
1.90
7.63
13.4
6.9
0.81
0.82
mmol/l
0.16
98
568
35
126
2.88
7.44
1.9
1.8
—
—
—
0
0
300
2294
1.57
7.29
5.3
4.2
0.00
0.00
estimate
0.50
38
486
149
958
1.72
7.28
4.2
2.6
0.86
1.00
mg/l
0.38
100
648
545
4825
1.80
7.07
22.1
12.2
13.63
13.54
%
0.26
539
4746
113
676
1.81
7.06
4.7
3.0
3.10
3.12
e6/l
0.00
63
360
99
569
1.87
7.03
6.3
4.2
29.61
30.16
s
0.51
99
560
185
1271
1.64
7.00
9.4
6.0
1.11
1.08
inr
0.12
39
449
301
2320
1.55
6.97
3.9
3.0
0.00
0.00
estimate
-0.00
38
466
159
1061
1.66
6.71
3.2
2.2
—
—
—
0
0
34
128
2.75
6.68
12.4
7.6
303.17
423.81
iu/ml
—
6
16
79
429
1.96
6.64
2.5
2.5
26.41
152.25
u/l
0.57
70
357
87
490
1.90
6.57
3.1
2.8
21.02
24.74
%
1.84
78
434
164
1112
1.64
6.48
2.2
2.7
2.42
2.61
mg/l
0.65
146
971
329
2635
1.50
6.09
12.1
6.8
54.32
53.90
%
0.29
310
2528
51
244
2.18
6.01
2.2
2.2
87.79
85.29
ml/min/173m2
0.15
14
86
493
4312
1.59
5.97
3.8
3.0
2.85
2.83
mmol/l
0.20
475
4106
146
984
1.62
5.85
1.7
1.6
1.69
1.38
mmol/l
1.95
136
884
118
755
1.69
5.78
5.6
2.9
4120.62
4108.52
umol/l
0.00
108
703
89
526
1.80
5.76
2.4
1.8
—
—
—
0
0
95
573
1.77
5.74
1.4
1.5
457.19
13010149.41
pmol/l
0.50
84
515
330
2668
1.48
5.69
12.2
6.9
31.36
31.71
%
0.26
310
2563
269
2100
1.48
5.47
3.5
2.6
—
—
—
0
0
106
672
1.69
5.36
4.0
4.4
13.76
12.97
mg/mmol
0.05
77
491
40
182
2.28
5.34
1.4
1.3
—
—
—
0
0
34
144
2.44
5.32
25.0
6.4
0.68
0.64
%
0.13
34
144
48
237
2.11
5.25
2.9
1.7
—
—
—
0
0
467
4088
1.51
5.13
3.4
2.7
1.32
1.22
mmol/l
1.70
447
3895
12
19
6.41
5.10
8.5
6.4
—
—
—
0
0
467
4096
1.50
5.01
10.0
7.3
105.03
103.20
ml/min/173m2
1.05
358
3125
487
4310
1.52
4.99
3.7
3.0
4.55
4.62
mmol/l
0.79
472
4131
416
3576
1.45
4.88
4.9
3.1
45.45
32.65
u/l
0.89
399
3444
313
2560
1.43
4.78
4.0
3.0
70.25
72.17
ug/l
0.11
299
2415
102
662
1.64
4.70
1.4
1.3
20.91
18.88
nmol/l
0.80
91
582
83
511
1.72
4.67
9.5
4.1
6.20
7.11
umol/l
0.20
71
424
482
4279
1.49
4.66
3.6
2.9
1.31
1.40
mmol/l
6.31
467
4090
12
22
5.54
4.62
5.4
3.7
—
—
—
0
0
86
539
1.69
4.53
22.7
6.8
0.62
1.48
mmol/l
0.98
72
443
206
1578
1.45
4.42
2.1
1.5
1.88
2.00
g/l
0.63
114
936
145
1042
1.50
4.28
2.4
2.3
58.99
32.97
ng/l
0.36
53
418
23
91
2.58
4.17
2.0
1.3
—
—
—
0
0
19
69
2.81
4.05
10.5
2.7
—
—
—
0
0
224
1770
1.41
3.97
1.6
1.5
1.59
2.06
u/ml
0.22
48
421
106
724
1.55
3.94
1.3
1.2
18.56
20.72
iu/ml
0.14
27
193
48
264
1.88
3.93
1.8
1.6
285.15
177.37
u/ml
1.90
33
138
69
424
1.70
3.92
1.6
1.3
230.76
276.68
u/ml
0.20
63
395
91
602
1.59
3.88
3.4
2.8
833.32
939.81
ng/l
0.08
53
302
35
173
2.08
3.87
21.1
12.0
1.59
1.41
%
0.27
35
173
23
97
2.42
3.69
1.7
1.3
—
—
—
0
0
23
97
2.42
3.69
1.7
1.3
—
—
—
0
0
34
172
2.03
3.55
21.6
12.1
0.73
0.68
%
0.31
34
172
47
267
1.82
3.50
1.8
1.6
—
—
—
0
0
18
69
2.65
3.50
45.4
11.0
69.32
68.86
%
0.03
18
69
10
22
4.60
3.44
1.6
1.3
—
—
—
0
0
41
225
1.88
3.41
10.9
5.5
3.21
3.16
g/l
0.08
41
218
7
10
7.06
3.37
2.0
1.4
0.34
0.86
mg/l
—
7
5
8
14
5.77
3.35
3.3
4.8
—
—
—
0
0
73
475
1.60
3.34
5.3
4.6
295.12
805.40
ng/l
0.89
57
366
17
65
2.66
3.32
6.9
2.3
743.29
668.98
e6/l
0.24
17
65
33
171
1.98
3.25
22.3
12.2
93.94
94.70
%
0.36
33
171
155
1188
1.40
3.19
4.1
3.3
0.00
0.01
estimate
1.08
35
471
627
6036
2.10
3.16
24.9
13.8
269.67
259.33
e9/l
3.78
613
5869
16
61
2.66
3.15
3.4
1.7
—
—
—
0
0
16
61
2.66
3.15
3.4
1.7
—
—
—
0
0
13
44
2.99
3.15
2.8
1.6
—
—
—
0
0
10
25
4.05
3.09
3.1
2.6
1456.50
692.72
u/ml
—
10
25
10
25
4.05
3.09
1.5
1.5
—
—
—
0
0
16
62
2.62
3.06
1.0
1.1
—
—
—
0
0
9
21
4.33
3.00
2.8
2.7
9.44
17.69
umol/l
—
9
21
10
26
3.89
2.99
5.6
10.7
—
—
—
0
0
51
313
1.68
2.95
1.5
1.4
—
—
—
0
0
627
6048
2.04
2.94
24.9
13.7
4.70
4.68
e12/l
0.63
610
5873
129
973
1.41
2.90
2.7
3.2
111.27
109.25
ug/g
0.03
108
785
627
6053
2.01
2.85
25.0
13.9
138.48
138.36
g/l
0.08
621
5975
626
6041
1.98
2.83
26.9
13.9
41.23
41.82
%
0.34
599
5774
13
47
2.80
2.83
1.3
1.1
—
—
—
0
0
13
47
2.80
2.83
1.3
1.1
—
—
—
0
0
13
47
2.80
2.83
1.3
1.1
—
—
—
0
0
13
47
2.80
2.83
1.3
1.1
—
—
—
0
0
29
152
1.95
2.79
1.2
1.2
—
—
—
0
0
17
72
2.40
2.74
5.5
5.7
1.39
1.40
mmol/l
0.02
17
72
13
48
2.74
2.73
1.3
1.1
—
—
—
0
0
58
376
1.60
2.73
2.0
1.9
5.23
6.62
u/l
1.15
42
295
36
206
1.79
2.67
2.8
1.6
107.89
100.90
u/ml
—
8
26
15
61
2.49
2.63
5.9
5.4
3.72
3.83
mmol/l
0.42
15
61
14
55
2.58
2.63
1.5
1.7
—
—
—
0
0
29
156
1.90
2.61
1.2
1.2
—
—
—
0
0
7
15
4.70
2.60
3.1
4.0
—
—
—
0
0
140
1091
1.36
2.58
3.3
2.0
—
—
—
0
0
28
150
1.91
2.55
5.6
4.3
24.61
27.21
nmol/l
0.54
28
145
62
418
1.53
2.48
1.4
1.6
254.61
296.26
mu/l
1.16
54
368
15
63
2.41
2.48
1.0
1.0
—
—
—
0
0
14
57
2.49
2.46
2.3
2.1
—
—
—
0
0
15
64
2.38
2.40
1.0
1.1
37.70
41.17
mg/l
—
10
52
210
1756
1.29
2.34
3.6
2.9
—
—
—
0
0
37
223
1.70
2.33
11.4
5.0
180.16
163.65
%
0.65
37
218
9
28
3.24
2.31
1.4
1.1
—
—
—
0
0
246
2102
1.27
2.30
2.1
1.8
—
—
—
0
0
11
41
2.71
2.21
5.2
4.2
24.91
25.90
umol/l
0.09
11
41
17
80
2.16
2.20
3.3
1.7
—
—
—
0
0
17
80
2.16
2.20
3.3
1.7
—
—
—
0
0
8
24
3.36
2.18
2.3
1.3
—
—
—
0
0
6
14
4.32
2.15
3.2
3.6
154.17
169.49
ug/l
—
6
14
62
432
1.48
2.15
2.0
1.8
—
—
—
0
0
33
198
1.70
2.13
1.5
1.3
—
—
—
0
0
222
1889
1.27
2.12
2.8
2.4
—
—
—
0
0
59
413
1.47
2.01
12.2
6.5
1.15
1.08
mmol/l
0.07
41
304
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
70
2.17
1.99
12.7
12.8
0.33
0.37
u/ml
—
8
43
27
158
1.74
1.92
1.6
1.7
—
—
—
0
0
14
65
2.18
1.89
1.0
1.1
—
—
—
0
0
75
556
1.39
1.89
3.0
2.5
4991.21
4333.67
u/l
0.09
22
227
91
697
1.36
1.88
1.3
1.2
1.21
6.62
u/ml
3.33
29
281
17
86
2.00
1.86
1.2
1.2
—
1.09
—
0
7
17
86
2.00
1.86
1.2
1.2
—
—
—
0
0
13
59
2.23
1.85
3.9
1.6
—
—
—
0
0
6
17
3.55
1.84
6.7
6.8
—
—
—
0
0
6
17
3.55
1.84
6.5
6.7
—
—
—
0
0
14
66
2.15
1.83
4.6
2.2
—
—
—
0
0
54
380
1.46
1.81
2.0
1.8
6.12
12.24
iu/l
4.43
35
293
8
29
2.78
1.79
5.6
3.0
—
—
—
0
0
8
29
2.78
1.79
5.6
3.0
—
—
—
0
0
15
74
2.05
1.76
3.7
1.6
—
—
—
0
0
61
442
1.42
1.76
1.4
1.3
—
—
—
0
0
203
1744
1.24
1.73
2.8
2.2
—
—
—
0
0
8
32
2.52
1.60
1.4
1.4
61.63
74.78
umol/l
—
8
32
17
93
1.85
1.53
1.1
1.4
357.14
339.34
ug/g
—
7
48
5
15
3.35
1.52
4.6
8.1
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
67
507
1.36
1.52
1.1
1.1
—
—
—
0
0
33
218
1.54
1.52
4.4
3.2
7.75
7.26
umol/l
0.07
24
174
48
657
0.71
1.50
1.1
1.4
—
—
—
0
0
5
16
3.14
1.44
30.2
19.6
0.26
0.46
umol/l
—
5
16
9
41
2.21
1.37
1.7
1.8
—
—
—
0
0
6
23
2.62
1.37
5.8
2.7
16.27
19.10
ug/l
—
6
23
23
143
1.63
1.37
1.1
1.1
—
9.68
—
0
10
27
175
1.57
1.36
2.3
2.0
40.50
41.02
u/l
0.05
22
165
13
68
1.93
1.34
2.1
2.3
—
—
—
0
0
27
176
1.56
1.33
1.6
1.6
1.26
1.18
g/l
0.63
27
161
18
106
1.72
1.30
3.4
1.7
—
—
—
0
0
12
62
1.95
1.28
1.0
1.1
—
—
—
0
0
11
55
2.02
1.28
1.6
1.6
—
—
—
0
0
12
63
1.92
1.23
1.8
1.6
—
—
—
0
0
26
172
1.53
1.22
1.6
1.6
0.26
0.23
g/l
0.68
26
160
15
86
1.76
1.20
2.2
1.5
—
—
—
0
0
8
38
2.12
1.18
1.1
1.3
—
—
—
0
0
36
257
1.42
1.18
1.3
1.4
—
—
—
0
0
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
37
269
1.40
1.11
1.9
1.8
—
—
—
0
0
5
21
2.39
1.09
3.0
1.5
—
—
—
0
0
7
32
2.20
1.08
2.7
1.2
—
—
—
0
0
61
482
1.29
1.08
2.2
2.5
0.92
1.30
ug/l
2.09
56
446
48
367
1.33
1.07
2.3
2.7
37.73
22.02
%
—
8
87
18
113
1.61
1.06
1.2
1.2
—
2.61
—
0
11
19
122
1.57
1.03
1.2
1.2
—
29.73
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
34
2.07
1.03
1.4
1.1
—
—
—
0
0
24
163
1.49
1.03
2.0
1.9
221.75
223.00
pmol/l
0.01
24
156
17
107
1.60
1.00
3.4
1.6
—
—
—
0
0
18
115
1.58
1.00
1.2
1.2
—
12.37
—
0
17
7
35
2.01
1.00
1.1
1.0
—
—
—
0
0
26
365
0.70
0.99
1.8
1.8
—
—
—
0
0
5
23
2.18
0.98
2.2
1.3
—
—
—
0
0
9
51
1.78
0.95
1.2
1.5
—
—
—
0
0
60
487
1.26
0.88
1.2
1.3
90.13
134.67
iu/ml
0.44
15
179
8
43
1.87
0.87
2.1
2.1
0.14
0.15
nmol/l
—
8
33
20
137
1.47
0.85
1.5
1.9
—
—
—
0
0
0
28
0.00
0.76
0.0
2.1
—
6.91
—
0
22
10
59
1.71
0.76
4.5
1.5
—
—
—
0
0
26
193
1.36
0.74
1.4
1.6
0.00
0.10
iu/ml
—
5
38
5
26
1.93
0.70
2.0
1.0
—
—
—
0
0
7
41
1.71
0.70
2.7
1.5
—
—
—
0
0
102
898
1.16
0.68
3.4
1.9
—
—
—
0
0
23
171
1.36
0.66
1.7
1.6
—
—
—
0
0
11
70
1.58
0.65
1.6
2.0
—
—
—
0
0
33
262
1.27
0.62
1.1
1.1
9.04
7.50
u/ml
0.14
21
177
30
236
1.28
0.61
1.3
1.4
—
—
—
0
0
34
272
1.26
0.61
1.6
1.6
3.25
3.34
mg/l
0.04
28
179
17
122
1.40
0.60
1.2
1.2
—
—
—
0
0
8
52
1.55
0.59
1.1
1.1
—
—
—
0
0
15
107
1.41
0.55
3.1
9.0
24.16
23.72
mmol/l
0.20
15
102
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
29
235
1.24
0.49
1.2
1.2
—
—
—
0
0
28
343
0.81
0.48
3.1
2.7
31.41
31.18
%
0.03
22
254
30
363
0.82
0.46
1.9
1.7
—
—
—
0
0
20
156
1.29
0.45
1.6
1.1
—
—
—
0
0
30
247
1.22
0.45
2.1
1.8
31.37
35.96
nmol/l
0.60
30
242
7
51
1.38
0.44
2.0
1.1
—
—
—
0
0
9
127
0.70
0.43
2.1
2.1
—
—
—
0
0
13
173
0.75
0.42
1.4
2.1
19.69
28.11
u/ml
0.76
13
164
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
34
287
1.19
0.41
1.2
1.2
6.18
3.16
u/ml
0.50
23
186
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
5
34
1.47
0.40
3.0
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
2.5
—
1.70
—
0
18
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
7
102
0.68
0.40
2.7
3.7
2.46
3.55
e9/l
—
7
102
7
103
0.68
0.39
2.7
4.0
44.00
51.85
%
—
7
103
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
16
124
1.30
0.39
1.3
1.1
4.46
2.49
u/ml
—
9
59
11
80
1.38
0.38
3.0
2.0
0.99
4.54
ug/l
0.54
11
75
5
36
1.39
0.38
1.0
1.1
142.00
219.71
iu/ml
—
5
36
20
161
1.25
0.37
1.7
1.6
—
—
—
0
0
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
8
115
0.69
0.37
2.1
2.0
—
—
—
0
0
17
134
1.28
0.37
3.2
4.1
2.46
7.54
ug/l
—
10
98
9
71
1.27
0.36
6.0
1.9
—
—
—
0
0
6
42
1.43
0.35
4.0
2.9
37566.67
42930.95
ug/l
—
6
42
6
42
1.43
0.35
1.0
1.1
272.17
292.14
mg/l
—
6
36
10
73
1.38
0.34
3.1
1.4
—
—
—
0
0
34
391
0.86
0.33
1.5
1.6
—
—
—
0
0
23
192
1.21
0.32
1.2
1.2
—
—
—
0
0
6
47
1.28
0.32
2.3
1.4
—
—
—
0
0
513
5211
0.93
0.32
4.3
3.9
—
—
—
0
0
30
258
1.17
0.31
1.1
1.1
1.67
1.34
u/ml
0.11
18
155
7
56
1.25
0.29
1.6
1.3
—
—
—
0
0
22
186
1.19
0.28
1.4
1.3
2.82
4.25
ug/l
1.16
22
174
8
62
1.29
0.28
3.6
3.5
21.63
50.37
u/ml
—
8
49
59
538
1.11
0.28
1.3
1.4
—
—
—
0
0
9
72
1.25
0.25
2.3
1.4
—
—
—
0
0
13
106
1.23
0.23
1.7
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
0
10
0.00
0.21
0.0
13.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
11
89
1.24
0.21
1.7
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
8.12
—
0
13
39
427
0.91
0.20
1.4
1.4
—
—
—
0
0
29
260
1.12
0.19
1.2
1.1
3.96
2.90
u/ml
0.19
20
168
13
109
1.20
0.18
1.5
1.4
14.45
12.41
u/l
0.10
13
95
78
822
0.94
0.17
1.4
1.5
—
—
—
0
0
8
68
1.18
0.16
2.0
2.4
—
—
—
0
0
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
40
429
0.93
0.14
1.4
1.4
—
—
—
0
0
40
429
0.93
0.14
1.4
1.4
—
—
—
0
0
40
429
0.93
0.14
1.4
1.4
—
—
—
0
0
32
295
1.09
0.14
2.7
2.4
—
—
—
0
0
20
181
1.11
0.12
1.2
1.0
12.38
6.47
u/ml
0.34
12
104
11
96
1.15
0.10
1.2
1.4
2.60
3.54
u/ml
—
5
46
17
154
1.11
0.10
1.9
1.7
3.99
5.57
iu/l
—
7
58
6
55
1.09
0.09
1.2
1.5
—
—
—
0
0
30
317
0.94
0.08
1.3
1.5
—
—
—
0
0
8
75
1.07
0.07
1.1
1.6
3.84
5.35
umol/l
—
8
70
7
84
0.83
0.07
1.6
1.7
6.14
7.08
mmol/l
—
7
75
29
275
1.06
0.07
1.8
1.9
0.48
0.60
ug/l
0.51
16
101
37
357
1.04
0.04
1.5
1.3
261.03
259.15
miu/ml
0.01
15
176
17
180
0.94
0.04
1.8
1.8
—
—
—
0
0
97
955
1.02
0.04
1.6
1.5
—
—
—
0
0
11
119
0.92
0.04
1.4
1.7
7.95
7.41
mmol/l
0.37
11
114
46
470
0.98
0.02
1.4
1.5
—
—
—
0
0
17
162
1.05
0.02
1.2
1.0
0.56
0.79
u/ml
—
9
62
14
139
1.01
0.00
1.0
1.2
—
—
—
0
0
9
96
0.94
0.00
1.6
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
99
0.91
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
5
51
0.98
-0.00
1.6
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
0.33
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
481.11
—
0
9
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_READING – Disorders in reading
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).